We found that APLN mRNA expression was significantly increased among HCC tumors with alterations in PI3K/Akt or Wnt/β-catenin pathways (Figure 2A), an observation that was validated in other tumor types (Figure 2B). This evidence concerns the gene APLN and hepatocellular carcinoma.